Yaso Therapeutics (United States)
Contraception without the side effects of pills, devices, or implants
Yaso Therapeutics develops a non-hormonal contraceptive gel using its patented PPCM drug platform, currently in Phase 1 clinical trials. The multipurpose platform uses nanoscale delivery to create a barrier against viru…
B2B/B2C (not explicitly stated), likely research/drug platform development with potential licensing or partnerships


